Research Article
Rate of Drug Coating Dissolution Determines In-Tissue Drug Retention and Durability of Biological Efficacy
Figure 4
Movat pentachrome stain of arterial sections 90 days posttreatment with Lutonix DCB (polysorbate/sorbitol/paclitaxel formulation; (a)) or IN.PACT DCB (urea/paclitaxel formulation; (b)). Areas of green staining indicate zones of SMC loss and proteoglycan deposition associated with local drug activity. Bar indicates 700 μm.
(a) |
(b) |